|ECR 2014 / B-0883|
|Patient outcome after pulmonary radiofrequency ablation: a prospective analysis of results from a single centre|
|This poster is published under an open license. Please read the disclaimer for further details.|
Thermal ablation has been used for a number of years in the treatment of both primary and secondary malignancies, mainly in the liver and lung. There is growing evidence to support its use, and the Royal College of Radiology predicts that it will have a more important role in the future. The technique is recognised by NICE (1) who acknowledge that further research is required to fully define its exact role. Because of the difficulty in performing true randomised controlled studies, much of the supportive data comes from prospective or retrospective observational studies based upon patient groups that are necessarily heterogeneous.
This single centre study aims to analyse factors affecting survival, recurrence and complication rates following RFA of pulmonary metastases, with a view to further supporting its use in selected patients with oligometastatic disease.
Thematically related posters
ECR 2014 / C-1942
Accuracy Of Tumour Targeting Using A CT-Compatible Robotic System – A Phantom Study
ECR 2014 / C-1151
A prospective analysis of radiofrequency ablation for liver metastases: a single centre study
ECR 2014 / B-0820
The impact of PET-CT in detecting non-nodal extrathoracic metastases in lung cancer compared to the staging CT